Parmar Kush

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Parmar Kush
CIK #0001664281
EDGAR Form CIK 2011 - 2026
3 [0001664281]
4 [0001664281]
Form 3/4/5 Subject 2011 - 2026
Entrada Therapeutics Inc
Parmar Kush
5AM Partners VI LLC
Camp4 Therapeutics Corp
5AM Opportunities II GP LLC
5AM Opportunities II LP
5AM Ventures VI LP
5AM Partners II LLC
5AM Partners VII LLC
5AM Ventures VII LP
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Entrada Therapeutics Inc TRDA
Common Stock
2025-11-14 Sell 200,000 $8.80 1,760,000
Entrada Therapeutics Inc TRDA
Common Stock
2025-07-09 Sell 6,935 $7.50 52,012
Entrada Therapeutics Inc TRDA
Common Stock
2025-07-09 Sell 20,065 $7.50 150,488
Entrada Therapeutics Inc TRDA
Common Stock
2025-07-01 Sell 18,578 $7.12 132,275
Entrada Therapeutics Inc TRDA
Common Stock
2025-07-01 Sell 6,422 $7.12 45,725
Entrada Therapeutics Inc TRDA
Common Stock
2025-06-30 Sell 18,578 $6.81 126,516
Entrada Therapeutics Inc TRDA
Common Stock
2025-06-30 Sell 6,422 $6.81 43,734
Entrada Therapeutics Inc TRDA
Common Stock
2025-06-27 Sell 19,265 $6.91 133,121
Entrada Therapeutics Inc TRDA
Common Stock
2025-06-27 Sell 55,735 $6.91 385,129
Entrada Therapeutics Inc TRDA
Stock Option (Right to Buy) · derivative
2025-06-11 Grant 19,000 $0.00
Camp4 Therapeutics Corp CAMP
Common Stock
2024-10-15 Conversion 302,770
Camp4 Therapeutics Corp CAMP
Common Stock
2024-10-15 Conversion 1,716,055
Camp4 Therapeutics Corp CAMP
Common Stock
2024-10-15 Buy 909,090 $11.00 9,999,990
Camp4 Therapeutics Corp CAMP
Series A Prime Preferred Stock · derivative
2024-10-15 Conversion 15,002,166
Camp4 Therapeutics Corp CAMP
Series B Preferred Stock · derivative
2024-10-15 Conversion 3,395,816
Camp4 Therapeutics Corp CAMP
Series B Preferred Stock · derivative
2024-10-15 Conversion 4,244,770
Skye Bioscience Inc SKYE
Common Stock
2024-09-13 Sell 11,758 $6.06 71,253
Skye Bioscience Inc SKYE
Common Stock
2024-09-13 Sell 2,000 $6.06 12,120
Skye Bioscience Inc SKYE
Common Stock
2024-09-13 Sell 79 $6.06 479
Skye Bioscience Inc SKYE
Common Stock
2024-09-11 Sell 1,440 $6.60 9,504
showing 20 of 190 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com